Testofen
Testofen, licence 80079446: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Fenugreek, Fenugreek extract
- Licence holder
- Natural Factors Nutritional Products Limited
- NPN or DIN-HM
- 80079446
- Status
- Active licence
- Licence date
- 14 August 2017
- Revision date
- 14 May 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Trigonella foenum-graecum Source : Trigonella foenum-graecum - Graine Extract : Matériel brut sec Extraction ratio : 33.000:1 Dry plant equivalent : 19800 milligramme Potency : 50.0 % Saponins | 600.0 milligramme | Not calculated |
Non-medicinal ingredients
NA, Silice, Stéarate de magnésium, Cellulose microcristalline, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 1.0 Jour(s) |
Uses authorised in Canada
Helps support testosterone production in men. Helps support normal levels of free testosterone in men. Helps support libido (sexual desire/drive/urge) in men. Helps support sexual arousal in healthy women. Helps improve sexual health including sexual cognition and behavior in women. Helps reduce symptoms of age related androgen decline, increases total and free testosterone levels (within the normal range) and increases libido, desire, and arousal for adult males suffering from age related androgen decline. Used in Herbal Medicine to help reduce elevated blood lipid levels/hyperlipidemia. Used in Herbal Medicine as a supportive therapy for the promotion of healthy glucose levels. Helps to increase women¿s sexual desire. Helps support women¿s healthy sex drive and libido. May help reduce menopausal symptoms such as hot flashes and night sweats.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80079446
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.